FDA - Tobacco Products: Principles for Designing and Conducting Tobacco Product Perception and Intention Studies

August 25, 2022

FDA - Tobacco Products: Principles for Designing and Conducting Tobacco Product Perception and Intention Studies.

August 2022

This final guidance is intended to help applicants (or “you”) design and conduct tobacco product perception and intention (TPPI) studies that may be submitted as part of a modified risk tobacco product application (MRTPA), a premarket tobacco product application (PMTA), or a substantial equivalence report (SE Report). TPPI studies are studies that can be used to assess, among other things, individuals’ perceptions of tobacco products, understanding of tobacco product information (e.g., labeling, modified risk information), and intentions to use tobacco products. It is possible for a TPPI study to also include an actual use component (e.g., an actual product utilized in a simulated use setting or a real environment of use); however, a discussion of actual use research is beyond the scope of this final guidance. This final guidance addresses the following scientific issues for applicants to consider as they design and conduct TPPI studies to support tobacco product applications:

  • Developing TPPI study aims and hypotheses
  • Designing quantitative and qualitative TPPI studies
  • Selecting and adapting measures of TPPI study constructs
  • Determining TPPI study outcomes
  • Selecting and justifying TPPI study samples
  • Analyzing TPPI study results

Download the Final Guidance Document

FINAL

Read the Federal Register Notice

Interested in learning more? Contact us today to find out how we can help with your global regulatory needs.

TAGS:

May 11, 2016

Recently Released Final Rule Extends FDA’s Authority to ALL Tobacco Products

On May 5, 2016, the FDA published a final rule, extending the Agency’s authority to all tobacco products, including, but not limited to, e-cigarettes, cigars, and hookah and pipe tobacco. This rule,...

September 12, 2016

FDA Updates Requirements Regarding Health Document Submissions for Tobacco Products

On Friday, September 9th, FDA announced the availability of a revised draft guidance, entitled “Health Document Submission Requirements for Tobacco Products.” The document was initially published in...

August 10, 2016

FDA Issues Final Rule Regarding its Refuse to Accept Procedures for Premarket Tobacco Product Submissions

On Monday, August 8th, the FDA issued a final rule outlining its refuse to accept policy for tobacco product submissions that do not meet the minimum threshold for acceptability for FDA review....